Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on May 13, 2008. The filing announces the financial results for the fiscal quarter ended March 31, 2008. The company is incorporated in Delaware and maintains its principal executive offices in Annapolis, MD.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the quarterly results have been issued via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It includes a standard disclaimer stating that the information in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Retrieve and review Exhibit 99.1 (the press release dated May 13, 2008) to obtain actual financial figures for the quarter ended March 31, 2008.
- Confirm the company's current operational status, as the filing date (2008) is historical.